| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | 5M BIOMED, LLC | 670 LAKE MEDLOCK DR | ALPHARETTA | GA | 30022-5677 | FULTON | USA | R43AG078718 | Highly Sensitive and Robust Blood Test Platform for Screening and Early Detection of Alzheimer's Disease | 000 | 1 | NIH | 2/10/2025 | $0 |
| | 2025 | 2021 | 5M BIOMED, LLC | 670 LAKE MEDLOCK DR | ALPHARETTA | GA | 30022-5677 | FULTON | USA | R41DK131761 | Small Intestine Targeted Fast Acting Oral Insulin Formulation | 000 | 1 | NIH | 10/16/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $306,433 ) |
| | 2024 | 2024 | 5M BIOMED, LLC | 670 LAKE MEDLOCK DR | ALPHARETTA | GA | 30022-5677 | FULTON | USA | R41HL169102 | Multi-functional magnetic nanorods for constructing theranostic extracellular vesicles for treating myocardial infarction | 000 | 1 | NIH | 11/28/2023 | $306,433 |
| | 2024 | 2022 | 5M BIOMED, LLC | 670 LAKE MEDLOCK DR | ALPHARETTA | GA | 30022-5677 | FULTON | USA | R43AG078718 | Highly Sensitive and Robust Blood Test Platform for Screening and Early Detection of Alzheimer's Disease | 000 | 1 | NIH | 8/6/2024 | $0 |
| | 2024 | 2021 | 5M BIOMED, LLC | 670 LAKE MEDLOCK DR | ALPHARETTA | GA | 30022-5677 | FULTON | USA | R41CA261544 | A New Class of Magnetic Nanoparticles for Glioma Targeted Drug Delivery | 000 | 1 | NIH | 1/11/2024 | $0 |
| | 2024 | 2021 | 5M BIOMED, LLC | 670 LAKE MEDLOCK DR | ALPHARETTA | GA | 30022-5677 | FULTON | USA | R41DK131761 | Small Intestine Targeted Fast Acting Oral Insulin Formulation | 000 | 1 | NIH | 2/16/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2021 | 5M BIOMED LLC | 670 LAKE MEDLOCK DR | ALPHARETTA | GA | 30022-5677 | FULTON | USA | R41DK131761 | Small Intestine Targeted Fast Acting Oral Insulin Formulation | 000 | 1 | NIH | 5/20/2023 | $0 |
| | 2023 | 2020 | 5M BIOMED, LLC | 670 LAKE MEDLOCK DR | ALPHARETTA | GA | 30022-5677 | FULTON | USA | R41CA254744 | Serum Detection of Medulloblastoma Metastasis | 000 | 1 | NIH | 4/17/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $399,840 ) |
| | 2022 | 2022 | 5M BIOMED LLC | 670 LAKE MEDLOCK DR | ALPHARETTA | GA | 30022-5677 | FULTON | USA | R43AG078718 | Highly Sensitive and Robust Blood Test Platform for Screening and Early Detection of Alzheimer's Disease | 000 | 1 | NIH | 8/9/2022 | $399,840 |
|
| Issue Date FY: 2021 ( Subtotal = $699,931 ) |
| | 2021 | 2021 | 5M BIOMED, LLC | 670 LAKE MEDLOCK DRIVE | JOHNS CREEK | GA | 30022-5677 | FULTON | USA | R41CA261544 | A New Class of Magnetic Nanoparticles for Glioma Targeted Drug Delivery | 000 | 1 | NIH | 7/20/2021 | $400,000 |
| | 2021 | 2021 | 5M BIOMED, LLC | 670 LAKE MEDLOCK DRIVE | JOHNS CREEK | GA | 30022-5677 | FULTON | USA | R41DK131761 | Small Intestine Targeted Fast Acting Oral Insulin Formulation | 000 | 1 | NIH | 9/20/2021 | $299,931 |
|
| Issue Date FY: 2020 ( Subtotal = $319,726 ) |
| | 2020 | 2020 | 5M BIOMED, LLC | 670 LAKE MEDLOCK DRIVE | JOHNS CREEK | GA | 30022-5677 | FULTON | USA | R41CA254744 | Serum Detection of Medulloblastoma Metastasis | 000 | 1 | NIH | 9/23/2020 | $319,726 |
|
|
